Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Connell

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Journal of Hypertension|November 1, 1993
Guanine nucleotide regulatory protein alterations in the Milan hypertensive rat strainC J Clark, G Milligan, J M Connell
International Journal of Oral and Maxillofacial Surgery|April 1, 1988
Hydrallazine-induced Sjögren's syndromeA Darwaza, P J Lamey, J M Connell
Current Opinion in Nephrology and Hypertension|June 9, 1998
Angiotensin converting enzyme gene polymorphisms and renal diseaseA G Jardine, N Padmanabhan, J M Connell
Current Opinion in Cardiology|November 21, 1998
New genetic concepts in hypertensive cardiovascular diseaseA F Dominiczak, B Jeffs, J M Connell
Diabetes|October 4, 2000
5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytesI P Salt, J M Connell, G W Gould
British Medical Journal (Clinical Research Ed.)|September 18, 1982
Metabolic consequences of salbutamol poisoning reversed by propranololJ M Connell, G M Cook, G T McInnes
Journal of Hypertension|June 1, 1994
Insulin and hypertensionA D Morris, J R Petrie, J M Connell
British Journal of Clinical Pharmacology|August 1, 1992
Therapeutic use of atrial natriuretic factorJ M Connell, A G Jardine, D B Northridge
Clinical and Experimental Pharmacology & Physiology. Supplement|November 11, 1998
Structure-function relationships of aldosterone synthase and 11 beta-hydroxylase enzymes: implications for human hypertensionA Fisher, E Davies, R Fraser, et al.
Lancet (London, England)|October 10, 1992
Patient guidance after 131I therapy: time for change?T E Hilditch, J M Connell, W D Alexander
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Journal of Hypertension|November 1, 1993
Guanine nucleotide regulatory protein alterations in the Milan hypertensive rat strainC J Clark, G Milligan, J M Connell
International Journal of Oral and Maxillofacial Surgery|April 1, 1988
Hydrallazine-induced Sjögren's syndromeA Darwaza, P J Lamey, J M Connell
Current Opinion in Nephrology and Hypertension|June 9, 1998
Angiotensin converting enzyme gene polymorphisms and renal diseaseA G Jardine, N Padmanabhan, J M Connell
Current Opinion in Cardiology|November 21, 1998
New genetic concepts in hypertensive cardiovascular diseaseA F Dominiczak, B Jeffs, J M Connell
Diabetes|October 4, 2000
5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytesI P Salt, J M Connell, G W Gould
British Medical Journal (Clinical Research Ed.)|September 18, 1982
Metabolic consequences of salbutamol poisoning reversed by propranololJ M Connell, G M Cook, G T McInnes
Journal of Hypertension|June 1, 1994
Insulin and hypertensionA D Morris, J R Petrie, J M Connell
British Journal of Clinical Pharmacology|August 1, 1992
Therapeutic use of atrial natriuretic factorJ M Connell, A G Jardine, D B Northridge
Clinical and Experimental Pharmacology & Physiology. Supplement|November 11, 1998
Structure-function relationships of aldosterone synthase and 11 beta-hydroxylase enzymes: implications for human hypertensionA Fisher, E Davies, R Fraser, et al.
Lancet (London, England)|October 10, 1992
Patient guidance after 131I therapy: time for change?T E Hilditch, J M Connell, W D Alexander
Pageof 19